Skip to main content
. 2015 Jul 27;2015:562935. doi: 10.1155/2015/562935

Figure 5.

Figure 5

Recipient but not donor and third-party Treg treatment induces donor-specific tolerance. Donor-specific tolerance was assessed by grafting of donor and third-party skin 4–6 weeks after BMT. Donor skin graft survival was significantly prolonged in BMT recipients treated with recipient Tregs (■ recipient Tregs, n = 4; ◆ donor Tregs, n = 4; ∆ third-party Tregs, n = 3; no Tregs, n = 5). Survival was calculated according to the Kaplan-Meier product limit method and compared between groups using the log-rank test (p < 0.05 for recipient Tregs versus all other groups).